The Trump administration offered “large sums of money” to a German research company for exclusive rights to a coronavirus vaccine, according to Die Welt.The German daily reported that the White House tried to convince CareVac, a biopharmaceutical firm based in Tuebingen, to move its research to the US. It quoted a German government official saying the offer was to develop the vaccine “only for the United States”.
